We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1
Read MoreHide Full Article
Watertown, MA-based maker of billing and medical practice management software, athenahealth Inc. reported adjusted earnings of 10 cents per share in the first quarter of fiscal 2017. Earnings missed the Zacks Consensus Estimate by a penny and declined almost 9% on a year-over-year basis.
The company posted revenues of $285.4 million, which also missed the Zacks Consensus Estimate of $297 million but increased 11.3% on a year-over-year basis.
Stock Performance
Year to date, athenahealth’s shares have decreased roughly 4.4%, comparing unfavorably with the Zacks categorized Medical Information Systems sub-industry’s addition of almost 19.2%. Moreover, the current level is way below the S&P 500’s return of 8.1% over the same time frame.
Quarter in Detail
athenahealth reported Business and Services revenues of $278.3 million, up 12.4% from the year-ago quarter. However, implementation and other segment posted revenues of $7.1 million, down 17.4% from the same quarter last year.
A strong client base has been a major growth driver for the company. Adjusted gross margin in the first quarter was 61.7% of net revenues compared with 62.0% a year ago.
The company registered operating margin of 7.7% in the first quarter compared with 9.4% in the year-ago quarter.
We believe applications like athenaClinicals, athenaClinicals-Streamlined, athenaInsight, athenaCommunicator, athenaOne, athenaCollector for Hospital and Health Systems are fortifying its market position.
Per management, the company expanded its network across ambulatory, hospital and population health platforms. The company’s network has grown to over 99,000 providers, 88 million patient records and 2.8 million covered lives at the end of the first quarter. Buoyed by stellar network expansion, the company is expected to see revenue and earnings growth over the long haul.
athenahealth, Inc. Price, Consensus and EPS Surprise
For fiscal 2017, the company expects revenues in the band of $1,210–$1,250 million.
Adjusted operating income is projected in the range of $120–$140 million. Annual bookings are expected at around $350–$400 million.
Zacks Rank & Stocks to Consider
athenahealth has a Zacks Rank #5 (Strong Sell).
Better-ranked stocks in the broader medical sector include Neovasc Inc. , Hologic, Inc. (HOLX - Free Report) and Sunshine Heart Inc . Notably, Neovasc and Hologic sport a Zacks Rank #1 (Strong Buy), while Sunshine Heart holds a Zacks Rank #2 (Buy) You can see the complete list of today’s Zacks #1 Rank stocks here.
Hologic has a long-term expected earnings growth rate of 11.33%. The stock has a solid one-year return of roughly 32.8%.
Sunshine Heart posted a positive earnings surprise of 58.24% in the last reported quarter. The stock recorded a stellar EPS growth rate (last 3–5 years of actual earnings) of almost 22%.
Neovasc saw a stellar gain of 14% over the last three months. The company projects sales growth of 102.88% for the current year.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Image: Bigstock
athenahealth (ATHN) Earnings, Revenues Miss Estimates in Q1
Watertown, MA-based maker of billing and medical practice management software, athenahealth Inc. reported adjusted earnings of 10 cents per share in the first quarter of fiscal 2017. Earnings missed the Zacks Consensus Estimate by a penny and declined almost 9% on a year-over-year basis.
The company posted revenues of $285.4 million, which also missed the Zacks Consensus Estimate of $297 million but increased 11.3% on a year-over-year basis.
Stock Performance
Year to date, athenahealth’s shares have decreased roughly 4.4%, comparing unfavorably with the Zacks categorized Medical Information Systems sub-industry’s addition of almost 19.2%. Moreover, the current level is way below the S&P 500’s return of 8.1% over the same time frame.
Quarter in Detail
athenahealth reported Business and Services revenues of $278.3 million, up 12.4% from the year-ago quarter. However, implementation and other segment posted revenues of $7.1 million, down 17.4% from the same quarter last year.
A strong client base has been a major growth driver for the company. Adjusted gross margin in the first quarter was 61.7% of net revenues compared with 62.0% a year ago.
The company registered operating margin of 7.7% in the first quarter compared with 9.4% in the year-ago quarter.
We believe applications like athenaClinicals, athenaClinicals-Streamlined, athenaInsight, athenaCommunicator, athenaOne, athenaCollector for Hospital and Health Systems are fortifying its market position.
Per management, the company expanded its network across ambulatory, hospital and population health platforms. The company’s network has grown to over 99,000 providers, 88 million patient records and 2.8 million covered lives at the end of the first quarter. Buoyed by stellar network expansion, the company is expected to see revenue and earnings growth over the long haul.
athenahealth, Inc. Price, Consensus and EPS Surprise
athenahealth, Inc. Price, Consensus and EPS Surprise | athenahealth, Inc. Quote
Guidance
For fiscal 2017, the company expects revenues in the band of $1,210–$1,250 million.
Adjusted operating income is projected in the range of $120–$140 million. Annual bookings are expected at around $350–$400 million.
Zacks Rank & Stocks to Consider
athenahealth has a Zacks Rank #5 (Strong Sell).
Better-ranked stocks in the broader medical sector include Neovasc Inc. , Hologic, Inc. (HOLX - Free Report) and Sunshine Heart Inc . Notably, Neovasc and Hologic sport a Zacks Rank #1 (Strong Buy), while Sunshine Heart holds a Zacks Rank #2 (Buy) You can see the complete list of today’s Zacks #1 Rank stocks here.
Hologic has a long-term expected earnings growth rate of 11.33%. The stock has a solid one-year return of roughly 32.8%.
Sunshine Heart posted a positive earnings surprise of 58.24% in the last reported quarter. The stock recorded a stellar EPS growth rate (last 3–5 years of actual earnings) of almost 22%.
Neovasc saw a stellar gain of 14% over the last three months. The company projects sales growth of 102.88% for the current year.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>